Metabolic and toxicological considerations regarding CGRP mAbs and CGRP antagonists to treat migraine in Covid-19 patients: a narrative review
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metabolic and toxicological considerations regarding CGRP mAbs and CGRP antagonists to treat migraine in Covid-19 patients: a narrative review
Authors
Keywords
-
Journal
Expert Opinion on Drug Metabolism & Toxicology
Volume -, Issue -, Pages -
Publisher
Informa UK Limited
Online
2023-11-06
DOI
10.1080/17425255.2023.2280221
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Headache attributed to SARS-CoV-2 infection, vaccination and the impact on primary headache disorders of the COVID-19 pandemic: A comprehensive review
- (2023) Edoardo Caronna et al. CEPHALALGIA
- Serum alpha-CGRP levels are increased in COVID-19 patients with headache indicating an activation of the trigeminal system
- (2023) Gabriel Gárate et al. BMC Neurology
- Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials
- (2023) Faraidoon Haghdoost et al. CEPHALALGIA
- Safety and tolerability of monoclonal antibodies targeting the CGRP pathway and gepants in migraine prevention: A systematic review and network meta-analysis
- (2023) Roberta Messina et al. CEPHALALGIA
- Long COVID and especially headache syndromes
- (2023) Claudio Tana et al. CURRENT OPINION IN NEUROLOGY
- Safety, tolerability, and efficacy of zavegepant 10 mg nasal spray for the acute treatment of migraine in the USA: a phase 3, double-blind, randomised, placebo-controlled multicentre trial
- (2023) Richard B Lipton et al. LANCET NEUROLOGY
- The Origins of Covid-19 — Why It Matters (and Why It Doesn’t)
- (2023) Lawrence O. Gostin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Post-authorization safety surveillance of Ad.26.COV2.S vaccine: Reports to the Vaccine Adverse Event Reporting System and v-safe, February 2021–February 2022
- (2023) Emily Jane Woo et al. VACCINE
- Guillain-Barré syndrome and COVID-19 vaccines: focus on adenoviral vectors
- (2023) Piotr Rzymski Frontiers in Immunology
- Estimation of COVID-19 mRNA Vaccine Effectiveness and COVID-19 Illness and Severity by Vaccination Status During Omicron BA.4 and BA.5 Sublineage Periods
- (2023) Ruth Link-Gelles et al. JAMA Network Open
- Primary headache disorders: From pathophysiology to neurostimulation therapies
- (2023) Ziying Wang et al. Heliyon
- Calcitonin Gene–Related Peptide Monoclonal Antibodies and Risk of SARS-CoV-2 Infection and Severe COVID-19 Outcomes Among Veterans With Migraine Disorder
- (2023) Kaicheng Wang et al. JAMA Network Open
- Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines
- (2022) Queenie Fernandes et al. ANNALS OF MEDICINE
- COVID-19 related outcomes among individuals with neurodegenerative diseases: a cohort analysis in the UK biobank
- (2022) Yihan Hu et al. BMC Neurology
- Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial
- (2022) CANADIAN MEDICAL ASSOCIATION JOURNAL
- Post-COVID-19 persistent headache: A multicentric 9-months follow-up study of 905 patients
- (2022) David Garcia-Azorin et al. CEPHALALGIA
- Long-Term Effectiveness of Three Anti-CGRP Monoclonal Antibodies in Resistant Chronic Migraine Patients Based on the MIDAS score
- (2022) Luigi Francesco Iannone et al. CNS DRUGS
- CGRP-monoclonal antibodies and SARS-CoV-2 vaccination
- (2022) Francesca Schiano di Cola et al. JOURNAL OF NEUROLOGY
- Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19
- (2022) Jennifer Hammond et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neutralizing antibody responses elicited by SARS-CoV-2 mRNA vaccination wane over time and are boosted by breakthrough infection
- (2022) John P. Evans et al. Science Translational Medicine
- Constipation Caused by Anti-calcitonin Gene-Related Peptide Migraine Therapeutics Explained by Antagonism of Calcitonin Gene-Related Peptide’s Motor-Stimulating and Prosecretory Function in the Intestine
- (2022) Peter Holzer et al. Frontiers in Physiology
- Migraine
- (2022) Michel D. Ferrari et al. Nature Reviews Disease Primers
- Changes in cognitive functioning after COVID‐19: A systematic review and meta‐analysis
- (2022) Lucia Crivelli et al. Alzheimers & Dementia
- Neurological Events Reported after COVID‐19 Vaccines: An Analysis of Vaccine Adverse Event Reporting System
- (2022) Jennifer A. Frontera et al. ANNALS OF NEUROLOGY
- Calcitonin Gene-Related Peptide (CGRP)-Targeted Monoclonal Antibodies and Antagonists in Migraine: Current Evidence and Rationale
- (2022) Fred Cohen et al. BIODRUGS
- The pandemic brain: Neuroinflammation in non-infected individuals during the COVID-19 pandemic
- (2022) Ludovica Brusaferri et al. BRAIN BEHAVIOR AND IMMUNITY
- Timing of headache after COVID-19 vaccines and its association with cerebrovascular events: An analysis of 41,700 VAERS reports
- (2022) David Garcia-Azorin et al. CEPHALALGIA
- Effectiveness of Paxlovid in Reducing Severe COVID-19 and Mortality in High Risk Patients
- (2022) Ronza Najjar-Debbiny et al. CLINICAL INFECTIOUS DISEASES
- Headache associated with COVID‐19: Epidemiology, characteristics, pathophysiology, and management
- (2022) Pedro Augusto Sampaio Rocha‐Filho HEADACHE
- The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates
- (2022) Lars Jacob Stovner et al. JOURNAL OF HEADACHE AND PAIN
- Headache onset after vaccination against SARS-CoV-2: a systematic literature review and meta-analysis
- (2022) Matteo Castaldo et al. JOURNAL OF HEADACHE AND PAIN
- Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study)
- (2022) Piero Barbanti et al. JOURNAL OF HEADACHE AND PAIN
- SARS-CoV-2 is associated with changes in brain structure in UK Biobank
- (2022) Gwenaëlle Douaud et al. NATURE
- Modeling of waning immunity after SARS-CoV-2 vaccination and influencing factors
- (2022) Laura Pérez-Alós et al. Nature Communications
- Cerebral Blood Flow and Other Predictors of Responsiveness to Erenumab and Fremanezumab in Migraine—A Real-Life Study
- (2022) Magdalena Nowaczewska et al. Frontiers in Neurology
- Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink
- (2022) Kayla E. Hanson et al. JAMA Network Open
- Salivary CGRP and erenumab treatment response: towards precision medicine in migraine
- (2022) Alicia Alpuente et al. ANNALS OF NEUROLOGY
- Protracted headache after COVID‐19: A case series of 31 patients from a tertiary headache center
- (2022) Leon S. Moskatel et al. HEADACHE
- Incidence and Outcomes of SARS-CoV-2 Infection in Older Adults Living with Dementia: A Population-Based Cohort Study
- (2022) Silvia Cascini et al. JOURNAL OF ALZHEIMERS DISEASE
- Long COVID headache
- (2022) Claudio Tana et al. JOURNAL OF HEADACHE AND PAIN
- Amitriptyline for post-COVID headache: effectiveness, tolerability, and response predictors
- (2022) Alicia Gonzalez-Martinez et al. JOURNAL OF NEUROLOGY
- Neutralization of the SARS-CoV-2 Omicron BA.4/5 and BA.2.12.1 Subvariants
- (2022) Panke Qu et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway
- (2022) Brian J. Willett et al. Nature Microbiology
- Oral Nirmatrelvir and Ritonavir in Nonhospitalized Vaccinated Patients With Coronavirus Disease 2019 (COVID-19)
- (2022) Sarju Ganatra et al. CLINICAL INFECTIOUS DISEASES
- Effectiveness of Molnupiravir in High-Risk Patients: A Propensity Score Matched Analysis
- (2022) Ronza Najjar-Debbiny et al. CLINICAL INFECTIOUS DISEASES
- Real-World Patient Experience of CGRP-Targeting Therapy for Migraine: a Narrative Review
- (2022) Ann M. Murray et al. Current Pain and Headache Reports
- Headache as a COVID ‐19 onset symptom and post‐ COVID ‐19 symptom in hospitalized COVID ‐19 survivors infected with the Wuhan, Alpha, or Delta SARS‐CoV ‐2 variants
- (2022) César Fernández‐de‐las‐Peñas et al. HEADACHE
- Epidemiological aspects of headache after different types of COVID ‐19 vaccines: An online survey
- (2022) Rehab Magdy et al. HEADACHE
- The relationship of headache as a symptom to COVID ‐19 survival: A systematic review and meta‐analysis of survival of 43,169 inpatients with COVID ‐19
- (2022) Víctor J. Gallardo et al. HEADACHE
- Zavegepant nasal spray for the acute treatment of migraine: A Phase 2/3 double‐blind, randomized, placebo‐controlled, dose‐ranging trial
- (2022) Robert Croop et al. HEADACHE
- The Mechanism-Based Inactivation of CYP3A4 by Ritonavir: What Mechanism?
- (2022) Nancy H. C. Loos et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients
- (2022) Piero Barbanti et al. JOURNAL OF HEADACHE AND PAIN
- Structural brain changes in patients with persistent headache after COVID-19 resolution
- (2022) Álvaro Planchuelo-Gómez et al. JOURNAL OF NEUROLOGY
- Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kong: an observational study
- (2022) Carlos K H Wong et al. LANCET
- Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge
- (2022) Ronen Arbel et al. NEW ENGLAND JOURNAL OF MEDICINE
- CGRP Plasma Levels Correlate with the Clinical Evolution and Prognosis of Hospitalized Acute COVID-19 Patients
- (2022) Manuela Rizzi et al. Viruses-Basel
- Immunologic aspects of migraine: A review of literature
- (2022) Mehrnaz Salahi et al. Frontiers in Neurology
- Serum Calcitonin Gene-Related Peptide α and β Levels are Increased in COVID-19 Inpatients
- (2022) Gabriel Gárate et al. ARCHIVES OF MEDICAL RESEARCH
- Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial
- (2022) Christopher C Butler et al. LANCET
- Incidence of Epilepsy and Seizures Over the First 6 Months After a COVID-19 Diagnosis: A Retrospective Cohort Study
- (2022) Maxime Taquet et al. NEUROLOGY
- Post-COVID-19 human memory impairment: A PRISMA-based systematic review of evidence from brain imaging studies
- (2022) Dan Shan et al. Frontiers in Aging Neuroscience
- Understanding thrombosis with thrombocytopenia syndrome after COVID-19 vaccination
- (2022) Alessandra Buoninfante et al. npj Vaccines
- Gepants for Acute and Preventive Migraine Treatment: A Narrative Review
- (2022) Jamir Pitton Rissardo et al. Brain Sciences
- Headache during SARS‐CoV‐2 infection as an early symptom associated with a more benign course of disease: a case‐control study
- (2021) Alicia Gonzalez‐Martinez et al. EUROPEAN JOURNAL OF NEUROLOGY
- Association between response to triptans and response to erenumab: real-life data
- (2021) Ilaria Frattale et al. JOURNAL OF HEADACHE AND PAIN
- Migraine treatment and COVID‐19 vaccines: no cause for concern
- (2021) Amy A. Gelfand et al. HEADACHE
- Increased worsening of amyotrophic lateral sclerosis patients during Covid-19-related lockdown in France
- (2021) Florence Esselin et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Neurological manifestations and complications of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis
- (2021) Ahmed Yassin et al. BMC Neurology
- Vaccination against COVID-19: insight from arterial and venous thrombosis occurrence using data from VigiBase
- (2021) David M. Smadja et al. EUROPEAN RESPIRATORY JOURNAL
- Diagnosis and Management of Headache
- (2021) Matthew S. Robbins JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Safety of anti-CGRP monoclonal antibodies in patients with migraine during the COVID-19 pandemic: Present and future implications
- (2021) E. Caronna et al. NEUROLOGIA
- Effects of the onabotulinumtoxinA follow-up delay in migraine course during the COVID-19 lockdown
- (2021) Alicia Gonzalez-Martinez et al. NEUROLOGICAL SCIENCES
- Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Indomethacin for refractory COVID or post-COVID headache: a retrospective study
- (2021) Abouch V. Krymchantowski et al. ACTA NEUROLOGICA BELGICA
- Refractory migraine profile in CGRP‐monoclonal antibodies scenario
- (2021) Marcello Silvestro et al. ACTA NEUROLOGICA SCANDINAVICA
- Central and peripheral nervous system involvement by COVID-19: a systematic review of the pathophysiology, clinical manifestations, neuropathology, neuroimaging, electrophysiology, and cerebrospinal fluid findings
- (2021) Juan I. Guerrero et al. BMC INFECTIOUS DISEASES
- The presence of headache at onset in SARS-CoV-2 infection is associated with long-term post-COVID headache and fatigue: A case-control study
- (2021) César Fernández-de-las-Peñas et al. CEPHALALGIA
- Headache as an acute and post COVID‐19 Symptom in COVID‐19 Survivors: A Meta‐analysis of the Current Literature
- (2021) César Fernández‐de‐las‐Peñas et al. EUROPEAN JOURNAL OF NEUROLOGY
- Toward a better understanding of persistent headache after mild COVID‐19: Three migraine‐like yet distinct scenarios
- (2021) Edoardo Caronna et al. HEADACHE
- Accelerated COVID-19 vaccine development: milestones, lessons, and prospects
- (2021) Karin Bok et al. IMMUNITY
- HMGB1, NLRP3, IL-6 and ACE2 levels are elevated in COVID-19 with headache: a window to the infection-related headache mechanism
- (2021) Hayrunnisa Bolay et al. JOURNAL OF HEADACHE AND PAIN
- Delayed headache after COVID-19 vaccination: a red flag for vaccine induced cerebral venous thrombosis
- (2021) David García-Azorín et al. JOURNAL OF HEADACHE AND PAIN
- Cytokine and interleukin profile in patients with headache and COVID-19: A pilot, CASE-control, study on 104 patients
- (2021) Javier Trigo et al. JOURNAL OF HEADACHE AND PAIN
- Energy and reactivity profile and proton affinity analysis of rimegepant with special reference to its potential activity against SARS-CoV-2 virus proteins using molecular dynamics
- (2021) T. Pooventhiran et al. JOURNAL OF MOLECULAR MODELING
- Disruptions of neurological services, its causes and mitigation strategies during COVID-19: a global review
- (2021) David García-Azorín et al. JOURNAL OF NEUROLOGY
- Neurology and neuropsychiatry of COVID-19: a systematic review and meta-analysis of the early literature reveals frequent CNS manifestations and key emerging narratives
- (2021) Jonathan P Rogers et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial
- (2021) Florence Ader et al. LANCET INFECTIOUS DISEASES
- Characterization of Headache in COVID-19: a Retrospective Multicenter Study
- (2021) Rafael César dos Anjos de Paula et al. MOLECULAR NEUROBIOLOGY
- Post-infection cognitive impairments in a cohort of elderly patients with COVID-19
- (2021) Yu-Hui Liu et al. Molecular Neurodegeneration
- Real-life assessment of erenumab in refractory chronic migraine with medication overuse headache
- (2021) Umberto Pensato et al. NEUROLOGICAL SCIENCES
- New daily persistent headache after SARS-CoV-2 infection: a report of two cases
- (2021) Fedele Dono et al. NEUROLOGICAL SCIENCES
- Atogepant for the Preventive Treatment of Migraine
- (2021) Jessica Ailani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine
- (2021) Paul T. Heath et al. NEW ENGLAND JOURNAL OF MEDICINE
- Frequency and phenotype of headache in covid-19: a study of 2194 patients
- (2021) David García-Azorín et al. Scientific Reports
- Bidirectional association between migraine and rheumatoid arthritis: two longitudinal follow-up studies with a national sample cohort
- (2021) Yoo Hwan Kim et al. BMJ Open
- Predictors of response to erenumab after 12 months of treatment
- (2021) Carlo Baraldi et al. Brain and Behavior
- Changes in Cerebral Blood Flow after Erenumab Treatment in Good and Non-Responders—A Pilot Study of Migraine Patients
- (2021) Magdalena Nowaczewska et al. Journal of Clinical Medicine
- Headache Attributed to Vaccination Against COVID-19 (Coronavirus SARS-CoV-2) with the ChAdOx1 nCoV-19 (AZD1222) Vaccine: A Multicenter Observational Cohort Study
- (2021) Carl H. Göbel et al. Pain and Therapy
- Effect of Vasoactive Intestinal Polypeptide on Development of Migraine Headaches
- (2021) Lanfranco Pellesi et al. JAMA Network Open
- Current Understanding of the Pathophysiology and Approach to Tension-Type Headache
- (2021) Stephanie J. Steel et al. Current Neurology and Neuroscience Reports
- Headache as a Symptom of COVID-19: Narrative Review of 1-Year Research
- (2021) Edoardo Caronna et al. Current Pain and Headache Reports
- Rapid response to galcanezumab and predictive factors in chronic migraine patients: A 3‐month observational, longitudinal, cohort, multicenter, Italian real‐life study
- (2021) Fabrizio Vernieri et al. EUROPEAN JOURNAL OF NEUROLOGY
- Clinic and genetic predictors in response to erenumab
- (2021) Chiara Zecca et al. EUROPEAN JOURNAL OF NEUROLOGY
- Psychological predictors of negative treatment outcome with Erenumab in chronic migraine: data from an open label long-term prospective study
- (2021) Sara Bottiroli et al. JOURNAL OF HEADACHE AND PAIN
- Ischemic stroke associated with COVID-19: a systematic review and meta-analysis
- (2021) Wenzhang Luo et al. JOURNAL OF NEUROLOGY
- Acute and post-acute neurological manifestations of COVID-19: present findings, critical appraisal, and future directions
- (2021) Ettore Beghi et al. JOURNAL OF NEUROLOGY
- Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients
- (2021) Robert L. Gottlieb et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico
- (2021) Lisa M. Dunkle et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19: A Review of Potential Treatments (Corticosteroids, Remdesivir, Tocilizumab, Bamlanivimab/Etesevimab, and Casirivimab/Imdevimab) and Pharmacological Considerations
- (2021) Salin Nhean et al. JOURNAL OF PHARMACY PRACTICE
- Eptinezumab in episodic migraine: A randomized, double-blind, placebo-controlled study (PROMISE-1)
- (2020) Messoud Ashina et al. CEPHALALGIA
- Ubrogepant: First Approval
- (2020) Lesley J. Scott DRUGS
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
- (2020) Zunyou Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effects of COVID‐19 on Parkinson's disease clinical features: a community‐based case‐control study
- (2020) Roberto Cilia et al. MOVEMENT DISORDERS
- Efficacy and safety of eptinezumab in patients with chronic migraine
- (2020) Richard B. Lipton et al. NEUROLOGY
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Spectrum of Headaches Associated With SARS‐CoV‐2 Infection: Study of Healthcare Professionals
- (2020) Jesús Porta‐Etessam et al. HEADACHE
- Frequency and type of red flags in patients with Covid‐19 and headache: a series of 104 hospitalized patients
- (2020) David García‐Azorín et al. HEADACHE
- Stopping lopinavir/ritonavir in COVID-19 patients: duration of the drug interacting effect
- (2020) Felix Stader et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Erenumab in the prevention of high‐frequency episodic and chronic migraine: Erenumab in Real Life in Italy (EARLY), the first Italian multicenter, prospective real‐life study
- (2020) Piero Barbanti et al. HEADACHE
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial
- (2020) Robert Croop et al. LANCET
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19: Coronavirus Vaccine Development Updates
- (2020) Jing Zhao et al. Frontiers in Immunology
- Pharmacokinetics, Pharmacodynamics and Drug–Drug Interactions of New Anti-Migraine Drugs—Lasmiditan, Gepants, and Calcitonin-Gene-Related Peptide (CGRP) Receptor Monoclonal Antibodies
- (2020) Danuta Szkutnik-Fiedler Pharmaceutics
- Evaluation of the Impact of the COVID-19 Lockdown in the Clinical Course of Migraine
- (2020) Alicia Gonzalez-Martinez et al. PAIN MEDICINE
- Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2019) Valery L Feigin et al. LANCET NEUROLOGY
- Rimegepant, an Oral Calcitonin Gene–Related Peptide Receptor Antagonist, for Migraine
- (2019) Richard B. Lipton et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ubrogepant for the Treatment of Migraine
- (2019) David W. Dodick et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial
- (2018) Vladimir Skljarevski et al. CEPHALALGIA
- Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults
- (2018) Cristina Tassorelli et al. CEPHALALGIA
- ARISE: A Phase 3 randomized trial of erenumab for episodic migraine
- (2018) David W Dodick et al. CEPHALALGIA
- Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
- (2018) CEPHALALGIA
- A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Erenumab on Exercise Time During a Treadmill Test in Patients With Stable Angina
- (2018) Christophe Depre et al. HEADACHE
- Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine
- (2018) David W. Dodick et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- CGRP as the target of new migraine therapies — successful translation from bench to clinic
- (2018) Lars Edvinsson et al. Nature Reviews Neurology
- Evaluation of Galcanezumab for the Prevention of Episodic Migraine
- (2018) Virginia L. Stauffer et al. JAMA Neurology
- Galcanezumab in chronic migraine
- (2018) Holland C. Detke et al. NEUROLOGY
- Blocking CGRP in migraine patients – a review of pros and cons
- (2017) Marie Deen et al. JOURNAL OF HEADACHE AND PAIN
- Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
- (2017) Stewart Tepper et al. LANCET NEUROLOGY
- Fremanezumab for the Preventive Treatment of Chronic Migraine
- (2017) Stephen D. Silberstein et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Controlled Trial of Erenumab for Episodic Migraine
- (2017) Peter J. Goadsby et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacokinetics interactions of monoclonal antibodies
- (2016) Nicola Ferri et al. PHARMACOLOGICAL RESEARCH
- Increased risk of rheumatoid arthritis in patients with migraine: a population-based, propensity score-matched cohort study
- (2016) Yi-Chia Wang et al. RHEUMATOLOGY INTERNATIONAL
- Calcitonin Gene-Related Peptide (CGRP): A New Target for Migraine
- (2015) Andrew F. Russo Annual Review of Pharmacology and Toxicology
- Triptans in the Acute Treatment of Migraine: A Systematic Review and Network Meta-Analysis
- (2015) Chris Cameron et al. HEADACHE
- Calcitonin Gene-Related Peptide: Physiology and Pathophysiology
- (2014) F. A. Russell et al. PHYSIOLOGICAL REVIEWS
- Calcitonin Gene-Related Peptide (CGRP) and Migraine Current Understanding and State of Development
- (2013) Marcelo E. Bigal et al. HEADACHE
- A Randomized, Placebo-Controlled Study of the Effects of Telcagepant on Exercise Time in Patients With Stable Angina
- (2012) B R Chaitman et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Effect of the calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant in human cranial arteries
- (2010) Lars Edvinsson et al. CEPHALALGIA
- Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura
- (2010) Jakob Møller Hansen et al. CEPHALALGIA
- Triptan Therapy in Migraine
- (2010) Elizabeth Loder NEW ENGLAND JOURNAL OF MEDICINE
- Role of calcitonin gene-related peptide (CGRP) in ovine burn and smoke inhalation injury
- (2009) Matthias Lange et al. JOURNAL OF APPLIED PHYSIOLOGY
- Alteration of Neuropeptides in the Lung Tissue Correlates Brain Death-Induced Neurogenic Edema
- (2009) Anne Barklin et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More